A Review of Therapies for <i>Clostridioides difficile</i> Infection
<i>Clostridioides difficile</i> is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of <i>Clostridioides difficile</i> infection (CDI), it remains a leading cause...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/14/1/17 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832589347669409792 |
|---|---|
| author | Faiza Morado Neha Nanda |
| author_facet | Faiza Morado Neha Nanda |
| author_sort | Faiza Morado |
| collection | DOAJ |
| description | <i>Clostridioides difficile</i> is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of <i>Clostridioides difficile</i> infection (CDI), it remains a leading cause of healthcare-associated infections. CDI is associated with significant clinical, social, and economic burdens. Therefore, it is imperative to provide optimal and timely therapy for CDI. We conducted a systematic literature review and offer treatment recommendations based on available evidence for the treatment and prevention of CDI. |
| format | Article |
| id | doaj-art-a67c7576b81243c6864a65c5985b8b51 |
| institution | Kabale University |
| issn | 2079-6382 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Antibiotics |
| spelling | doaj-art-a67c7576b81243c6864a65c5985b8b512025-01-24T13:18:33ZengMDPI AGAntibiotics2079-63822024-12-011411710.3390/antibiotics14010017A Review of Therapies for <i>Clostridioides difficile</i> InfectionFaiza Morado0Neha Nanda1Department of Pharmacy, Keck Medical Center, University of Southern California, Los Angeles, CA 90033, USADivision of Infectious Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA<i>Clostridioides difficile</i> is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of <i>Clostridioides difficile</i> infection (CDI), it remains a leading cause of healthcare-associated infections. CDI is associated with significant clinical, social, and economic burdens. Therefore, it is imperative to provide optimal and timely therapy for CDI. We conducted a systematic literature review and offer treatment recommendations based on available evidence for the treatment and prevention of CDI.https://www.mdpi.com/2079-6382/14/1/17<i>C. difficile</i> infectionrecurrent <i>C. difficile</i> infectionmetronidazolevacomycinfidaxomicinfecal microbiota transplantation |
| spellingShingle | Faiza Morado Neha Nanda A Review of Therapies for <i>Clostridioides difficile</i> Infection Antibiotics <i>C. difficile</i> infection recurrent <i>C. difficile</i> infection metronidazole vacomycin fidaxomicin fecal microbiota transplantation |
| title | A Review of Therapies for <i>Clostridioides difficile</i> Infection |
| title_full | A Review of Therapies for <i>Clostridioides difficile</i> Infection |
| title_fullStr | A Review of Therapies for <i>Clostridioides difficile</i> Infection |
| title_full_unstemmed | A Review of Therapies for <i>Clostridioides difficile</i> Infection |
| title_short | A Review of Therapies for <i>Clostridioides difficile</i> Infection |
| title_sort | review of therapies for i clostridioides difficile i infection |
| topic | <i>C. difficile</i> infection recurrent <i>C. difficile</i> infection metronidazole vacomycin fidaxomicin fecal microbiota transplantation |
| url | https://www.mdpi.com/2079-6382/14/1/17 |
| work_keys_str_mv | AT faizamorado areviewoftherapiesforiclostridioidesdifficileiinfection AT nehananda areviewoftherapiesforiclostridioidesdifficileiinfection AT faizamorado reviewoftherapiesforiclostridioidesdifficileiinfection AT nehananda reviewoftherapiesforiclostridioidesdifficileiinfection |